Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Business and government groups all over the Asia-Pacific area give a lot of money to study life sciences. Researchers are looking for safe ways to do things like study cells, keep cell cultures alive, and make new drugs. This is increasing the need for tools that count cells.
It's clear that automatic cell counting methods are being used in more and more places in APAC. These methods are fast, accurate, and can be used again and again, among other things. They make counting cells more accurate and reduce the amount of work that needs to be done by hand, which makes them very popular in research and hospital labs.
Stem cell research is getting more attention in the Asia-Pacific area. A big part of making stem cells grow and figuring out what they are is counting cells. As research into stem cell treatments and regenerative medicine grows, so does the need for accurate tools to count cells.
AI is being used in gadgets that count cells, which is a trend that stands out. When AI is used to run cell counting devices, the process goes faster and is more accurate. This makes it easier to work with large datasets and helps scientists learn helpful things from living samples that are hard to understand.
Point-of-care cell counting tools are becoming more popular because they can be used right where cells are needed and quickly. It is becoming more common to use these movable devices in hospitals, field studies, and other places with few resources. This is because they are simple to use and quickly count cells.
The Asia-Pacific Cell Counting market is getting more creative because businesses, research institutions, and study groups are working together and forming partnerships. It is the goal of these agreements to share resources and knowledge in order to make and use new tools for counting cells more quickly.
More and more is being done to let people know how important it is to count cells correctly in research and hospital settings. Through education programs, workshops, and training events, researchers and health care workers are getting better at using tools that count cells.
Large companies in the Asia-Pacific Cell Counting market want to be more present in the area. To meet the growing demand and take advantage of the many new opportunities in the Asia-Pacific life sciences market, this means opening regional offices, delivery networks, and factories.
Asia Pacific Cell Counting Market Highlights:
Asia Pacific Cell Counting Market Overview
Asia Pacific Cell Counting Market Size was valued at USD 1.98 Billion in 2023. The Global Asia Pacific Cell Counting industry is projected to grow from USD 2.16 Billion in 2024 to USD 4.47 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.67% during the forecast period (2024 - 2032). Cell counting is a type of method which is used for the counting or similar quantification of cells in the life sciences, including medical diagnosis and treatment of chronic diseases such as cancer.
Increase in the number of White Blood Cells (WBC) may indicate the possibility of cancerous growth in the body. Cell counting is also important for researchers and it is one of the major steps in most experiments, which helps in maintaining cell cultures. It is an important procedure needed to be carried out before any analytical procedures and determine abnormal growth of cells. Furthermore, cell counting is an important step in many experiments done in microbiology, hematology and other medical specialties.
Drivers that increases the Asia Pacific cell counting market are emphasis of cell counting in the diagnosis and treatment of life threatening diseases such as cancer, along with a wide range of cell counting applications. For instance, according to American Cancer Society, nearly 1,688,780 new cases of cancer are expected in 2017 in the U.S., and about 600,920 deaths due to it. Furthermore, growing “out of pocket” expenditure and use of new technologies in cell counting led to market’s growth. However, high pricing of the advanced cell counting systems and lack of awareness among researchers to use advanced cell counting techniques are restraining the growth of Asia Pacific cell counting market to a certain extent.
Figure 1: Market Synopsis of Cell Counting Market by Region, 2016 (%):
Sources: National Institute of Standards & Technology, Small Business Innovation Research (SBIR), U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Press Release, presentation, company website, annual reports, government records, journals expert interview
Asia Pacific Cell Counting Market Segmentation
The Asia Pacific cell counting market is segmented on the basis on instruments used for cell counting which are spectrophotometer, cell counter, hemocytometer, flow cytometer, hematology analyzer, microscope and other instruments.
On the basis of application of cell counting, cell structure study and cell analysis, quality control, cell viability, proliferation, signaling, identification, single cell analysis and other applications are includes.
It is also segmented on the basis of its end users which are hospitals, research institutes, pharmaceutical and biotechnology companies, clinical research organizations and other end users.
Regional Analysis of Asia Pacific Cell Counting Market
Asia Pacific cell counting market consists of countries namely China, Japan, Republic of Korea, India, Australia and rest of Asia Pacific. Increasing in number of diagnostic procedures for various chronic diseases and rising availability of cost effective diagnostic test drive the growth of the Asia Pacific cell counting market. Moreover, less complex regulations for drug development in Asian region has upsurged the growth of the Asia Pacific cell counting market.
Japan accounts the largest market share in Asia Pacific cell counting market in 2016. The growth of the Asia Pacific cell counting market is attributed to the development of medical devices in addition to research and development activities. Moreover, key market players are involved in the export of medical devices by focusing on developing markets to capture reasonable share in Asia Pacific cell counting market.
India is seen to be the fastest growing market for medical equipment manufactures. In India, the Asia Pacific cell counting market is increasing due to availability of low cost of raw material, better access to labor, increasing number of hospitals and healthcare centers. India is one of the top destinations for medical tourism, especially for orthopedic surgeries which is further influencing the market’s growth.
There is steady growth of this market in Australia and Republic of Korea during the forecast period from 2022-2030.
Key Players for Asia Pacific Cell Counting Market
Some of the key players in Asia Pacific cell counting market are:
- Bio-Rad Laboratories Inc. (U.S)
- General Electric Company (U.S)
- Agilent Technologies (U.S)
- PerkinElmer Inc. (U.S)
- Tecan Trading AG (Switzerland)
- BioTek Instruments, Inc. (U.S)
- Danaher (U.S)
- Merck KGaA (U.S)
- Thermo Fisher Scientific Inc. (U.S)
Intended Audience
- Research and development (R&D) companies
- Medical research laboratories
- Pharmaceutical companies
- Biotechnology companies
- Cell counting instruments manufacturers
- Cell counting instruments suppliers
- Academic medical institutes and universities
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
